Literature DB >> 11706120

NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL.

M Dichgans1, J Herzog, T Gasser.   

Abstract

Mutations in NOTCH3 are the cause of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary angiopathy causing stroke and vascular dementia. All CADASIL mutations identified so far result in the loss or gain of one cysteine residue within epidermal growth factor (EGF)-like repeat domains. Here an in-frame deletion causing a loss of three cysteine residues within EGF repeat 6 is reported. These data are consistent with the hypothesis that the change toward an odd number of cysteine residues within a given EGF repeat and therefore an unpaired, reactive cysteine residue is the common and critical molecular event in CADASIL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706120     DOI: 10.1212/wnl.57.9.1714

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  Single gene disorders causing ischaemic stroke.

Authors:  Saif S M Razvi; Ian Bone
Journal:  J Neurol       Date:  2006-06       Impact factor: 4.849

2.  A protein (ORF2) encoded by the latency-related gene of bovine herpesvirus 1 interacts with Notch1 and Notch3.

Authors:  Aspen Workman; Devis Sinani; Daraporn Pittayakhajonwut; Clinton Jones
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

3.  Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease.

Authors:  Rita João Guerreiro; Ebba Lohmann; Emma Kinsella; José Miguel Brás; Nga Luu; Nicole Gurunlian; Burcu Dursun; Basar Bilgic; Isabel Santana; Hasmet Hanagasi; Hakan Gurvit; Jesse Raphael Gibbs; Catarina Oliveira; Murat Emre; Andrew Singleton
Journal:  Neurobiol Aging       Date:  2011-12-06       Impact factor: 4.673

4.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in an Israeli family.

Authors:  Radi Shahien; Silvia Bianchi; Abdalla Bowirrat
Journal:  Neuropsychiatr Dis Treat       Date:  2011-06-20       Impact factor: 2.570

5.  Rare Variants in Neurodegeneration Associated Genes Revealed by Targeted Panel Sequencing in a German ALS Cohort.

Authors:  Stefanie Krüger; Florian Battke; Andrea Sprecher; Marita Munz; Matthis Synofzik; Ludger Schöls; Thomas Gasser; Torsten Grehl; Johannes Prudlo; Saskia Biskup
Journal:  Front Mol Neurosci       Date:  2016-10-13       Impact factor: 5.639

6.  Differences in proliferation rate between CADASIL and control vascular smooth muscle cells are related to increased TGFβ expression.

Authors:  Mahmod Panahi; Naeimeh Yousefi Mesri; Eva-Britt Samuelsson; Kirsten G Coupland; Charlotte Forsell; Caroline Graff; Saara Tikka; Bengt Winblad; Matti Viitanen; Helena Karlström; Erik Sundström; Homira Behbahani
Journal:  J Cell Mol Med       Date:  2018-03-13       Impact factor: 5.310

7.  Novel prion mutation (p.Tyr225Cys) in a Korean patient with atypical Creutzfeldt-Jakob disease.

Authors:  Eva Bagyinszky; YoungSoon Yang; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2019-08-02       Impact factor: 4.458

Review 8.  Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome.

Authors:  Vo Van Giau; Eva Bagyinszky; Young Chul Youn; Seong Soo A An; Sang Yun Kim
Journal:  Int J Mol Sci       Date:  2019-09-03       Impact factor: 5.923

9.  Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia.

Authors:  Alexey A Lagunin; Sergey M Ivanov; Tatyana A Gloriozova; Pavel V Pogodin; Dmitry A Filimonov; Sandeep Kumar; Rajesh K Goel
Journal:  Sci Rep       Date:  2020-01-14       Impact factor: 4.379

Review 10.  Genetic architecture of common non-Alzheimer's disease dementias.

Authors:  Rita Guerreiro; Elizabeth Gibbons; Miguel Tábuas-Pereira; Celia Kun-Rodrigues; Gustavo C Santo; Jose Bras
Journal:  Neurobiol Dis       Date:  2020-05-19       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.